Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model.

MLA

Piepho, Arden B., et al. “Micro-Dystrophin Gene Therapy Demonstrates Long-Term Cardiac Efficacy in a Severe Duchenne Muscular Dystrophy Model.” Molecular Therapy. Methods & Clinical Development, vol. 28, Feb. 2023, pp. 344–54. EBSCOhost, https://doi.org/10.1016/j.omtm.2023.02.001.

APA

Piepho, A. B., Lowe, J., Cumby, L. R., Dorn, L. E., Lake, D. M., Rastogi, N., Gertzen, M. D., Sturgill, S. L., Odom, G. L., Ziolo, M. T., Accornero, F., Chamberlain, J. S., & Rafael-Fortney, J. A. (2023). Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model. Molecular Therapy. Methods & Clinical Development, 28, 344–354. https://doi.org/10.1016/j.omtm.2023.02.001

Chicago

Piepho, Arden B, Jeovanna Lowe, Laurel R Cumby, Lisa E Dorn, Dana M Lake, Neha Rastogi, Megan D Gertzen, et al. 2023. “Micro-Dystrophin Gene Therapy Demonstrates Long-Term Cardiac Efficacy in a Severe Duchenne Muscular Dystrophy Model.” Molecular Therapy. Methods & Clinical Development 28 (February): 344–54. doi:10.1016/j.omtm.2023.02.001.